Overview

4.9 out of 5 (18 Reviews)

Credits

1.00

Pharmacology Credits

1.00

Post Assessment Questions

5

Start Date

1 Jan 2023

Last Review Date

1 Jan 2023

Expiration Date

31 Dec 2024

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Afatinib, a tyrosine kinase inhibitor, is a widely used medication for non-small cell lung carcinoma. Afatinib is a targeted therapy that irreversibly inhibits the ErbB family of tyrosine kinases. It is the first-line FDA-approved indication to treat locally advanced or metastatic non-small cell lung cancer (NSCLC) that harbors nonresistant epidermal growth factor receptor (EGFR) mutations, and the second-line treatment of advanced squamous non-small cell lung cancer (NSCLC). Afatinib is also under investigation as monotherapy in patients with HER2-positive breast cancer who had progressed despite trastuzumab treatment. This activity educates health care providers on the indications, mechanism of action, adverse reactions, and toxicity. It also reviews the necessity of enhancing health care outcomes by improving the interprofessional approach to managing the drug.

Target Audience

This activity has been designed to meet the educational needs of nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the mechanism of action of afatinib.
  • Describe the possible adverse effects of afatinib.
  • Summarize the appropriate monitoring for patients using afatinib.
  • Review interprofessional team strategies for enhancing care coordination and communication to advance afatinib use and improve outcomes.
  • Outline the indications of Afatinib

Disclosures

StatPearls requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. None of the planners of this educational activity have any relevant financial relationships to disclose.

COMMERCIAL SUPPORT: This activity has received NO commercial support.

Continuing Education Accreditation Information

Credit provided by Continuing Education, Inc, and StatPearls, LLC.

In support of improving patient care, this activity has been jointly planned and implemented by Continuing Education, Inc./University at Sea® and StatPearls, LLC. Continuing Education, Inc, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is designated for 1.00 ANCC contact hours which includes 1.00 hours of pharmacology.

Instructions for Credit

  1. Register for the activity and create a StatPearls login.     
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content in the activity.
  4. Choose the best answer to each activity test question. To receive credit, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment.
  6. Obtain a certificate.

For information on the applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Disclaimer

Faculty may discuss investigational products or off-label uses of products regulated by the US Food and Drug Administration. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls specifically disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Cancellation Policy: Cancellations must be received in writing and a money-back guarantee is provided if not completely satisfied.

  • StatPearlsand and Continuing Education, Inc, reserve the right to cancel any course due to unforeseen circumstances. StatPearls and Continuing Education, Inc, will not be responsible for other expenses incurred by the participant in the unlikely event that the program is canceled.

Medium or Media Used:

  • Computer Requirements: Internet Access
  • E-mail Address

Equal Opportunity

  • StatPearls and Continuing Education are Equal Opportunity/Affirmative Action/Equal Access Institutions. 

 

 
 

Reviews

Alana H. on 8/23/2021

thomas on 8/30/2021

Adam T. on 10/17/2021

John S. on 11/24/2021

Anne C. on 3/28/2022

Stephen A. on 6/1/2022

Diane L. on 6/2/2022

Shannon j. on 6/27/2022

Nicole F. on 8/30/2022

Sara M. on 9/20/2022

Li Mei L. on 11/22/2022

Chet B. on 12/5/2022

Li Mei L. on 2/7/2023

Daniel H. on 4/13/2023

Daniel H. on 6/9/2023

Amber S. on 6/12/2023

Michele N. on 7/8/2023

Dawn B. on 8/22/2023

Unlimited Nurse Practitioner CE

Stay up to date on the latest medical knowledge with 6685 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7951 hours of CE.

6 Month Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$199 per half year per user

1 Year Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$299 per 1 year per user